Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

A B cell-dependent mechanism restrains T cell transendothelial migration.

Saba JD.

Nat Med. 2015 May 7;21(5):424-6. doi: 10.1038/nm.3858. No abstract available.

PMID:
25951526
2.

Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamus.

Ramírez D, Saba J, Carniglia L, Durand D, Lasaga M, Caruso C.

Mol Cell Endocrinol. 2015 Apr 16. pii: S0303-7207(15)00194-X. doi: 10.1016/j.mce.2015.04.008. [Epub ahead of print]

PMID:
25892444
3.

Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs.

Degagné E, Pandurangan A, Bandhuvula P, Kumar A, Eltanawy A, Zhang M, Yoshinaga Y, Nefedov M, de Jong PJ, Fong LG, Young SG, Bittman R, Ahmedi Y, Saba JD.

J Clin Invest. 2014 Dec;124(12):5368-84. doi: 10.1172/JCI74188. Epub 2014 Oct 27.

4.

S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer.

Degagné E, Saba JD.

Clin Exp Gastroenterol. 2014 Jun 30;7:205-14. doi: 10.2147/CEG.S43453. eCollection 2014. Review.

5.

Tracking hippo in the cancer jungle.

Suh JH, Saba JD.

Chem Biol. 2014 Jul 17;21(7):803-4. doi: 10.1016/j.chembiol.2014.07.002.

PMID:
25036773
6.

Performance of 21 HPV vaccination programs implemented in low and middle-income countries, 2009-2013.

Ladner J, Besson MH, Rodrigues M, Audureau E, Saba J.

BMC Public Health. 2014 Jun 30;14:670. doi: 10.1186/1471-2458-14-670.

7.

Diversity within the O-linked protein glycosylation systems of acinetobacter species.

Scott NE, Kinsella RL, Edwards AV, Larsen MR, Dutta S, Saba J, Foster LJ, Feldman MF.

Mol Cell Proteomics. 2014 Sep;13(9):2354-70. doi: 10.1074/mcp.M114.038315. Epub 2014 Jun 10.

PMID:
24917611
9.

The substantive equivalence of transgenic (Bt and Chi) and non-transgenic cotton based on metabolite profiles.

Modirroosta BH, Tohidfar M, Saba J, Moradi F.

Funct Integr Genomics. 2014 Mar;14(1):237-44. doi: 10.1007/s10142-013-0355-y. Epub 2013 Dec 28.

PMID:
24374853
10.

Predictors of protective behaviors among American travelers to the 2009 Hajj.

Balaban V, Stauffer W, Hammad A, Afgarshe M, Abd-Alla M, Ahmed Q, Memish Z, Saba J, Harton E, Palumbo G, Marano N.

J Epidemiol Glob Health. 2013 Dec;3(4):187-96. doi: 10.1016/j.jegh.2013.08.001. Epub 2013 Oct 11.

PMID:
24206790
11.

Increasing access to care for chronic myeloid leukemia patients: assessment of a scaling-up program.

Ladner J, Tekinturhan E, Tavolacci MP, Audureau E, Saba J.

J Health Care Poor Underserved. 2013 Nov;24(4):1486-97. doi: 10.1353/hpu.2013.0160.

PMID:
24185146
12.

Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression.

de la Garza-Rodea AS, Baldwin DM, Oskouian B, Place RF, Bandhuvula P, Kumar A, Saba JD.

FASEB J. 2014 Jan;28(1):506-19. doi: 10.1096/fj.13-233155. Epub 2013 Oct 24.

13.

Cancer of the Indiana Pouch: a case report and review of the literature.

Saba N, Saba J, Janbain M, Bitar C, Lipsky A, Blaya M.

Clin Genitourin Cancer. 2013 Dec;11(4):e30-4. doi: 10.1016/j.clgc.2013.07.001. Epub 2013 Sep 27. No abstract available.

PMID:
24075928
14.

Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

Tekinturhan E, Audureau E, Tavolacci MP, Garcia-Gonzalez P, Ladner J, Saba J.

BMC Health Serv Res. 2013 Aug 10;13:304. doi: 10.1186/1472-6963-13-304.

15.

Bortezomib in plasmablastic lymphoma: a case report and review of the literature.

Saba NS, Dang D, Saba J, Cao C, Janbain M, Maalouf B, Safah H.

Onkologie. 2013;36(5):287-91. doi: 10.1159/000350325. Epub 2013 Apr 5. Review.

PMID:
23689224
16.

Prevention of mother-to-child HIV transmission in resource-limited settings: assessment of 99 Viramune Donation Programmes in 34 countries, 2000-2011.

Ladner J, Besson MH, Rodrigues M, Sams K, Audureau E, Saba J.

BMC Public Health. 2013 May 14;13:470. doi: 10.1186/1471-2458-13-470.

17.

Artemisinin-based combination therapy availability and use in the private sector of five AMFm phase 1 countries.

Davis B, Ladner J, Sams K, Tekinturhan E, de Korte D, Saba J.

Malar J. 2013 Apr 22;12:135. doi: 10.1186/1475-2875-12-135.

18.
19.

Development and validation of a multilateral index to determine economic status in developing countries: the Patient Financial Eligibility Tool (PFET).

Saba J, Audureau E, Bizé M, Koloshuk B, Ladner J.

Popul Health Manag. 2013 Apr;16(2):82-9. doi: 10.1089/pop.2012.0049. Epub 2012 Dec 31.

PMID:
23276290
20.

The chromosome-centric human proteome project: a call to action.

Hühmer AF, Paulus A, Martin LB, Millis K, Agreste T, Saba J, Lill JR, Fischer SM, Dracup W, Lavery P.

J Proteome Res. 2013 Jan 4;12(1):28-32. doi: 10.1021/pr300933p. Epub 2012 Dec 21.

PMID:
23259496
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk